MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$21,226,107
Pre-tax loss
-$21,223,018
Income tax (expense)
benefit
$3,089
Other income
$1,332,207
Loss from operations
-$22,555,225
Collaboration revenue
$7,945,753
Total operating
expenses
$30,500,978
Research and development
$16,734,549
General and
administrative
$11,449,466
In-process research and
development
$2,289,602
Depreciation
$27,361
Back
Back
Income Statement
source: myfinsight.com
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)